Delivery Order SPE2DR25D2206-SPE2DR26F9PU5
Award Date 2/6/26
Potential Completion Date 3/2/26
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $45,802.80 on August 1, 2025, for the supply of CABENUVA ER 600 mg-900 mg suspension in 6 mL units. This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by August 22, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement action under the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,184.22 to AmerisourceBergen Drug Corp for CABENUVA ER 600 MG-900 MG suspension (6 mL) on January 15, 2026, with an ultimate completion date of February 6, 2026. This firm fixed-price delivery order was competitively awarded without set-aside designation and is being performed at the awardee's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $40,921.10 firm fixed-price delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 8, 2026, for the supply of CABENUVA ER 600 MG-900 MG suspension in 6 mL quantities. The contract, which is not set-aside, has an ultimate completion date of January 30, 2026, and will be performed at the awardee's location in Conshohocken, Pennsylvania. This delivery order is issued under Amerisourcebergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $8,184.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp for CABENUVA ER 600 MG-900 MG suspension (6 mL) on January 9, 2026, with completion targeted for February 2, 2026. This delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. CABENUVA is a long-acting injectable antiretroviral medication used in HIV treatment, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $8,044.86 to AmerisourceBergen Drug Corp for CABENUVA ER 600 MG-900 MG suspension (6 mL) on December 22, 2025, with completion scheduled for January 14, 2026. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 27, 2025, for the supply of CABENUVA ER 600 MG-900 MG suspension in 6 mL quantities, valued at $38,169.00 under a firm fixed-price arrangement. This non-competitive set-aside delivery order will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of October 20, 2025. The award represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency Medical Supply Chain awarded a $38,169 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for CABENUVA ER 600 MG-900 MG Suspension in 6 mL units. This firm fixed-price delivery order, which represents a child contract action under AmerisourceBergen's larger pharmaceutical supply agreements, is scheduled for completion by September 18, 2025, with performance at the company's Conshohocken, Pennsylvania location. The award was competitively awarded with...
- The Defense Logistics Agency awarded a delivery order valued at $4,092.11 to AmerisourceBergen Drug Corp for CABENUVA ER 600 MG-900 MG suspension (6ML) on January 21, 2026, with completion targeted for February 11, 2026. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a delivery order valued at $7,633.82 to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Cabenuva ER 600 mg-900 mg suspension in 6 ml units. This firm fixed price delivery order, with an ultimate completion date of November 18, 2025, represents a non-set-aside competitive award. The product will be delivered to the company's headquarters in Conshohocken, Pennsylvania. Cabenuva is a long-acting injectable antiretroviral combination therapy...
- The Defense Logistics Agency awarded a $24.6K delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Cabenuva ER 600 mg-900 mg suspension (6 mL) through February 5, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery...